Consent for Dual Enrollment Prevention Check
Central Registry Inquiries from Non-Opioid Treatment Programs (OTP)
Due to the recent changes to 42 CFR Part 2 regulations which serve to protect patient records created by federally assisted programs for the treatment of substance use disorders, non-OTPs are now eligible to query a central registry, in order to determine whether their patients are already receiving opioid treatment through a member program. Patient consent is required.
The purpose of this is to prevent duplicative enrollments in substance use disorder (SUD) care, duplicative prescriptions for SUD treatment, and to inform prescriber decision making regarding the prescribing of opioid medications or other prescribed substances.
To make an inquiry to ADMH’s Central Registry, please complete the form below and email to Valencia.Pernell@mh.alabama.gov. Please allow up to 72 hours for a response.